Literature DB >> 25557434

Tumor thickness as a prognostic factor in extramammary Paget's disease.

Takamichi Ito1, Yumiko Kaku, Konosuke Nagae, Misa Nakano-Nakamura, Takeshi Nakahara, Yoshinao Oda, Akihito Hagihara, Masutaka Furue, Hiroshi Uchi.   

Abstract

Extramammary Paget's disease (EMPD) is a rare tumor and a widely accepted classification system specific for the disease has not been established. To elucidate prognostic factors of EMPD, we conducted a retrospective review of 145 patients with 155 EMPD lesions and investigated clinicopathological factors using univariate and multivariate analyses. We also explored tumor thickness and metastatic lymph nodes using detection analysis to determine cut-off points for survival. All patients were Japanese (88 men and 57 women), with EMPD in the genital (82.8%), perianal (3.4%) and axillary regions (1.4%). In the remaining cases (12.4%), there were lesions at two or more regions. Univariate analysis revealed the following prognostic factors: perianal location, presence of nodules, invasion depth, tumor thickness, number of metastatic nodes and serum carcinoembryonic antigen level. Both tumor thickness and perianal location retained statistical significance in multivariate analysis (hazard ratio, 1.39; 95% confidence interval, 1.12-1.72; P = 0.0024; hazard ratio, 50.72; 95% confidence interval, 4.20-612.63; P = 0.0020; respectively). The signal detection analysis indicated tumor thickness of more than 3 mm and three or more metastatic lymph nodes as cut-off points for survival. In conclusion, tumor thickness and the number of metastatic lymph nodes closely correlated with patient outcome and these factors could be suitable for the tumor and node classification.
© 2014 Japanese Dermatological Association.

Entities:  

Keywords:  extramammary Paget's disease; prognosis; sentinel lymph node biopsy; survival; tumor thickness

Mesh:

Substances:

Year:  2014        PMID: 25557434     DOI: 10.1111/1346-8138.12764

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  12 in total

Review 1.  [Extramammary Paget's disease].

Authors:  I Cosgarea; A Zaremba; U Hillen
Journal:  Hautarzt       Date:  2019-09       Impact factor: 0.751

2.  Cutaneous angiosarcoma of the head and face: a single-center analysis of treatment outcomes in 43 patients in Japan.

Authors:  Takamichi Ito; Hiroshi Uchi; Takeshi Nakahara; Gaku Tsuji; Yoshinao Oda; Akihito Hagihara; Masutaka Furue
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-25       Impact factor: 4.553

Review 3.  Prognostic Factors of Extramammary Paget's Disease.

Authors:  Naohito Hatta
Journal:  Curr Treat Options Oncol       Date:  2018-08-15

Review 4.  Current Management and Treatment of Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Takamichi Ito
Journal:  Curr Treat Options Oncol       Date:  2022-04-04

5.  Wide local excision of perianal Paget's disease with gluteal flap reconstruction: an interdisciplinary approach.

Authors:  Daniel J Borsuk; George Melich; Jeremy Sugrue; Jed Calata; Iris A Seitz; John J Park; Leela M Prasad; Slawomir J Marecik
Journal:  J Vis Surg       Date:  2016-09-19

6.  Perianal Pagetoid Intraepithelial Carcinoma.

Authors:  Suanga Sisodia; Robin Boushey; Goo Lee; Celia Marginean; Marcio M Gomes; Gaurav Bhattacharya; Kristopher Dennis
Journal:  Case Rep Gastroenterol       Date:  2017-03-03

7.  Tumor Wide Horizontal Invasion Predicts Local Recurrence for Scrotal Extramammary Paget's Disease.

Authors:  Lujia Wang; Chenchen Feng; Minwei Zhou; Zhongwen Zhou; Guanxiong Ding; Peng Gao; Qiang Ding; Zhong Wu
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

8.  NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.

Authors:  Maho Murata; Takamichi Ito; Yuka Tanaka; Yumiko Kaku-Ito; Masutaka Furue
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

9.  Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Yumiko Kaku-Ito; Masutaka Furue; Takamichi Ito
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

10.  CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Yumiko Kaku-Ito; Yoshinao Oda; Takamichi Ito
Journal:  Front Oncol       Date:  2021-07-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.